Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06070714 · ClinicalTrials.gov registry record · NA

Efficiency and Safety of Holmium Laser With Moses Technology Versus SuperPulsed Laser System With Thulium Fiber Laser on Renal Stones

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
178
Enrollment target

NCT06070714 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 178 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06070714, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
178 participants
Enrollment target

Study Summary

This is a prospective randomized controlled trial designed to assess the efficacy and safety of Lumenis® Pulse™ P120H holmium laser system with the Moses technology (holmium laser with pulse modulation) versus the Soltive™ SuperPulsed Laser System with the thulium fiber laser (thulium fiber laser), in dusting of renal stones during ureteroscopy with laser lithotripsy. 310 participants will be enrolled across 5 research sites.

Interventions

  • DEVICE Holmium laser with pulse modulation
  • DEVICE Thulium fiber laser

Trial Details

FieldValue
Enrollment Target 178 participants
Start Date 2023-09-07
Est. Completion 2025-10-31
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT06070714

The ClinicalTrials.gov registry entry for NCT06070714 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Holmium laser with pulse modulation is the first listed.

NCT06070714 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06070714 about?

NCT06070714 is a clinical study titled "Efficiency and Safety of Holmium Laser With Moses Technology Versus SuperPulsed Laser System With Thulium Fiber Laser on Renal Stones". This is a prospective randomized controlled trial designed to assess the efficacy and safety of Lumenis® Pulse™ P120H holmium laser system with the Moses technology (holmium laser with pulse modulation) versus the Soltive™ SuperPulsed Laser System with the thulium fiber laser (thulium fiber laser), ...

What is the current status of trial NCT06070714?

This trial is currently completed. It is a NA study. The enrollment target is 178 participants. The study started on 2023-09-07. Estimated completion is 2025-10-31.

What interventions are being tested in trial NCT06070714?

The interventions under investigation include: Holmium laser with pulse modulation (DEVICE), Thulium fiber laser (DEVICE).

Who is sponsoring clinical trial NCT06070714?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.